Identification of key genes, pathways and potential therapeutic agents for liver fibrosis using an integrated bioinformatics analysis

BACKGROUND: Liver fibrosis is often a consequence of chronic liver injury, and has the potential to progress to cirrhosis and liver cancer. Despite being an important human disease, there are currently no approved anti-fibrotic drugs. In this study, we aim to identify the key genes and pathways gove...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhan, Zhu, Chen, Yuhe, Duan, Yuanqin, Li, Lin, Mew, Kenley, Hu, Peng, Ren, Hong, Peng, Mingli
Formato: Online Artículo Texto
Lenguaje:English
Publicado: PeerJ Inc. 2019
Materias:
Bioinformatics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6432904/
https://www.ncbi.nlm.nih.gov/pubmed/30923657
http://dx.doi.org/10.7717/peerj.6645

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6432904/
https://www.ncbi.nlm.nih.gov/pubmed/30923657
http://dx.doi.org/10.7717/peerj.6645

Ejemplares similares